A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours (Q33398444)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours |
scientific article |
Statements
1 reference
A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours (English)
1 reference
Patrick Schöffski
1 reference
Ahmad Awada
1 reference
Herlinde Dumez
1 reference
Thierry Gil
1 reference
Sylvie Bartholomeus
1 reference
Pascal Wolter
1 reference
Martine Taton
1 reference
Holger Fritsch
1 reference
Patricia Glomb
1 reference
Gerd Munzert
1 reference
24 November 2011
1 reference
1 reference
48
1 reference
179-186
1 reference
Identifiers
1 reference
1 reference